Ondansetron for prophylaxis of spinal morphine induced nausea during early rooming in breastfeeding: a randomized placebo controlled trial

Phase 4

Completed

• Conditions: After cesarean delivery under spinal anesthesia with morphine, postoperative nausea and vomiting (PONV) may disturb maternal activity during breastfeeding and consequently reduce the successful rate o; Ondansetron prophylaxis nausea spinal morphine breastfeeding

• Registration Number: TCTR20160216003
• Lead Sponsor: Faculty of Medicine, Chulalongkorn University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-05-31
• Study Start: 2016-02-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 160

Inclusion Criteria

18-50 years of age, ASA physical status I-II, singleton, gestational age over 37 weeks and scheduled for elective cesarean section under successful spinal anesthesia.

Exclusion Criteria

Allergy to any study medication, cardiovascular and neurological disease, renal impairment or refusal of breastfeeding within 8 hours after delivery.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence of nausea 8 hour chi square

Secondary Outcome Measures

Name	Time	Method
severity of nausea, incidences of nausea,vomiting, itching, 8 and 24 hours chi square and chi square for trend for Likert's scale